Atlas Trials

Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine

Clinical trial NCT00794235 · COMPLETED

Trial details

NCT number
NCT00794235
Sponsor
University of Zurich
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma Stage III or IVNo Prior Chemotherapy
Start date
2008-12-01
Primary completion
2009-11-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.